Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models.

Southern, P; Pankhurst, QA; (2017) Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models. Int J Hyperthermia 10.1080/02656736.2017.1365953 . (In press).

https://ift.tt/2HVba4H